I think there is a little bit more to this atricle than just a simple push for moving r&d to emerging markets to get cheaper labor. For example, I heard some ph

I think there is a little bit more to this atricle than just a simple push for moving r&d to emerging markets to get cheaper labor. For example, I heard some pharmaceutical companies bhave started developing labs in Russia, not to reduce costs, but as a way to make it easier to get past a lot of beaurocratic red tape. I had heard there were some laws requiring the company to use only Russian companies in the transportation of their pills, the pharma used some companies not approved by the state, and thus were slapped with some big antitrust suits. In order to make the suits go away, they set up a big, rather costly, lab facility, and then they didn't have to worry any more about these regulations. (I heard the story recently on NPR, but I can't find a link to a written story about it). I guess what I'm getting at, is that I wonder how much of these R&D facilities are being set up as a way to reduce costs as some people are speculating, and how many are being forced in order to side step red tape and continue pushing their products into new markets?